Bayer’s Wrist is Slapped by 30 States
Make a commentBy Ed Silverman // January 24th, 2007 // 10:42 am
The German drugmaker will pay $8 million to settle allegations it failed to to adequately warn consumers about risks associated with its Baycol cholesterol pill. You’ll recall that Baycol, which debuted in 1988, was withdrawn in 2001 after being linked to a potentially fatal muscle reaction that could lead to kidney failure.
As part of the deal, Bayer hasn’t admitted any wrongdoing, but has agreed to register relevant clinical drug trials and drug studies, and to post the results of those studies online, the AP reported.
It’s a pity that it takes legal action by state governments to get a drugmaker to register its clinical trials. And let’s be honest, this fine is small change.
What side effects will this cause?
[tags]Baycol, Bayer, Clinical Trials[/tags]